the aid library

LIST OPTIONS

Filter

2439

COVID Reference 2021.6 ES

Kamps, B.S.; C. Hoffmann, A. Gualani Gualani; and J. Garcia-Rosales Delgado (2021) CC

6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)

Download (560)

View PDF (992)

Technical guide for debris management - The Haitian experience 2010 - 2012

UN Development Programme (2013) CC

The building damage assessment, conducted between March 2010 and February 2011 by the Government of Haiti and the United Nations system, showed that more than 400,000 buildings were damaged or destroyed, of which approximately 218,000 could be occupied without repairs (green category), 105,000 were ... more

External Link

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies

Maguire, B.; Dahal, P.; Rashan, S.; et al. (2021) CC

PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697 Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop... more

Download (528)

View PDF (929)

Diarrhea and Dehydration Module 6

Yu C, Lougee D, Murno JR American Academy of Pediatrics (2016) C1

Poor sanitary conditions in disaster-stricken areas result in higher risk for diarrheal illness in vulnerable populations, especially children. This disease negatively impacts the nutritional status of affected children and causes significant morbidity and mortality. Early di... more

Download (366)

View PDF (402)

Guidelines for Management of Healthcare Waste as per Biomedical Waste Management Rules

Directorate General of Health Services Ministry of Health & Family Welfare ,India (2016) CC

Health Care Facilities (HCFs) are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house trans... more

Download (413)

View PDF (426)

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO

Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t... more

Download (225)

View PDF (263)

Manejo de las reacciones adversas por tratamiento etiologico de la enfermedad de chagas

Ministerio de salud y deportes, Bolivia (2007) C2

El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d... more

Download (1357)

View PDF (2248)

Donaciones de dispositivos médicos: consideraciones relativas a su solicitud y suministro

Organización Panamericana de la Salud (2011) C_WHO

WHO Medical Devices Donations - SPANISH Version - Las tecnologías sanitarias son fundamentales en un sistema de salud operativo. Los dispositivos médicos, en concreto, son cruciales para la prevención, el diagnóstico, el tratamiento y la rehabilitación de enfermedades. Estos documentos están d... more

Download (230)

View PDF (232)

Plano Nacional de Expansão da Testagem para Covid-19. - PNE-Teste

Ministerio da Saude, Brasilia (2019) CC

O Ministério da Saúde atualiza o Diagnosticar para Cuidar com o PLANO NACIONAL DE EXPANSÃO DA TESTAGEM PARA COVID-19 (PNE-Teste) que tem a finalidade de expandir o diagnóstico da covid-19 por meio do teste rápido de antígeno (TR-AG), para uso em indivíduos sintomáticos e assintomáticos, par... more

Download (135)

View PDF (100)

La enfermedad de Chagas en las Américas: análisis de la situación actual y revisión estratégica de la agenda regio- nal. Informe final, 14-16 de marzo del 2023, Medellín (Colombia)

Pan American Health Organization PAHO (2023) C_WHO

Con todas estas consideraciones, se han actualizado los aspectos clave de la vigilancia, la detec- ción, el diagnóstico, el tratamiento, la prevención, el control y la eliminación de la enfermedad, presentados por comisión de trabajo y ordenados según las conclusiones, las recomendaciones y ... more

Download (343)

View PDF (419)

Disability Data Collection in Community-based Rehabilitation

Sunil Deepak, Franesca Ortali, Geraldine Mason Halls, Tulgamaa Damdinsuren, Enhbuyant Lhagvajav, Steven Msowoya, Malek Qutteina, Jayanth Kumar Disability, CBR & Inclusive Development Journal (DCIDJ) (2016) CC

Today there are Community-based Rehabilitation (CBR) programmes in a large number of countries. In many countries, the CBR approach is a part of the national rehabilitation services. However, there is a lack of reliable data about persons with disabilities who benefit from CBR and the kind of benefi... more

Download (337)

View PDF (254)

Continuité des services de santé essentiels : outil d’évaluation des établissements
recommended

Organisation Mondiale de la Santé OMS (2021) C_WHO

Module appartenant à la série d’évaluations des capacités des services de santé dans le cadre de la pandémie de COVID-19: orientations provisoires, 12 mai 2021. L'outil d'évaluation de la continuité des services de santé essentiels : Facility Assessment Tool peut être utilisé par les pa... more

Download (488)

View PDF (702)

Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

World Health Organization (WHO) (2017) C_WHO

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a... more

Download (273)

View PDF (289)

Pandemic influenza preparedness framework: progress report

World Health Organization WHO (2022) C_WHO

The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame... more

Download (258)

View PDF (173)

2020 Heart Failure Society of South Africa perspective on the 2016 European Society of Cardiology Chronic Heart Failure Guidelines

Hitzeroth, J.; Mpe, M.; Klug, E. et al. The South African Medical Journal (2020) CC

Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t... more

Download (1757)

View PDF (2665)

The World Medcines situation 2011 Rational use of Medicines

World Health Organization WHO (2011) C_WHO

Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there... more

Download (311)

View PDF (294)

Whole-genome sequencing for surveillance of antimicrobial resistance

World Health Organization WHO; Global Antimicrobial Resistance and Use Surveillance System (GLASS) (2020) C_WHO

Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control.... more

External Link

Post Traumatic Stress Disorder in Children Sexsual Abuse

Eglantina Dervishi Academic Journal of Interdisciplinary Studies MCSER Publishing (2015) CC

The aim of this study is to research deeply on the post-traumatic stress disorder in sexually abused children. Proving the presence of forms of the disorder in children and the their treatment mode will be in the center of the study. The methods used to conduct this study will be a literature review... more

Download (147)

View PDF (166)

Epidemiology and Challenges of Managing COPD in sub-Saharan Africa

Magitta, N.F.; Sciences, A. Acta Scientific Medical Sciences (2018) CC2

There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more

Download (433)

View PDF (659)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Continuité des services de santé essentiels : outil d’évaluation des établissements recommended

Continuité des services de santé essentiels : outil d’évaluation des établissements
recommended